Jaguar Animal Health Inc (JAGX)

0.60
0.08 15.00
NASDAQ : Health Care
Prev Close 0.52
Open 0.54
Day Low/High 0.54 / 0.64
52 Wk Low/High 1.19 / 4.70
Volume 187.03K
Avg Volume 241.60K
Exchange NASDAQ
Shares Outstanding 14.44M
Market Cap 7.94M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Jaguar Animal Health And Napo Pharmaceuticals Announce Filing Of Two Orphan Drug Designation Applications With FDA For Mytesi For Serious Unmet Medical Needs

Jaguar Animal Health, Inc. (NASDAQ: JAGX) (Jaguar), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Lisa Conte, CEO Of Jaguar Animal Health And Napo Pharmaceuticals, To Present At The Southern California Investment Forum May 31, 2017 In Los Angeles

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Napo Pharmaceuticals' New Mytesi Video Calls Attention To The Continuing Widespread Problem Of Diarrhea In People Living With HIV/AIDS

Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, which launched Mytesi ® in...

Jaguar Animal Health And Napo Pharmaceuticals Appoint Dr. Pravin Chaturvedi To Chair Scientific Advisory Board

Jaguar Animal Health, Inc. (NASDAQ: JAGX) (Jaguar), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Signs Distribution Agreement For Japan For Neonorm Foal & Neonorm Calf

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar And Napo Issue Commercial Updates

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

After Clearing Valeant Litigation, Jaguar and Napo Pharmaceuticals Reunite

After Clearing Valeant Litigation, Jaguar and Napo Pharmaceuticals Reunite

The animal health company combines with its former owner in a reverse merger.

Jaguar Animal Health Stock Rises on Napo Pharma Merger

Jaguar Animal Health Stock Rises on Napo Pharma Merger

Jaguar Animal Health (JAGX) stock was surging by 20% to $1.14 on Friday morning

Jaguar Animal Health Stock Skyrocketing on Napo Pharma Merger

Jaguar Animal Health Stock Skyrocketing on Napo Pharma Merger

Jaguar Animal Health and Napo Pharmaceuticals have signed a merger agreement.

Jaguar Animal Health And Napo Pharmaceuticals Enter Definitive Merger Agreement

Napo Pharmaceuticals, Inc. ("Napo"), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and Jaguar Animal Health, Inc.

Jaguar Enters Exclusive Evaluation Period With Multinational Animal Health Pharmaceutical Firm Regarding Equilevia, Jaguar's Drug Product Candidate For Equine Gastric Ulcer Syndrome

Jaguar Animal Health, Inc. (NASDAQ: JAGX) (Jaguar), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Seeks MUMS Designation For Canalevia For Exercise-Induced Diarrhea In Dogs

Jaguar Animal Health, Inc. (NASDAQ:JAGX) (Jaguar), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health To Participate In 29th Annual ROTH Conference The Week Of March 13th In Orange County, California

Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Study Supporting Herd-wide Reduction In Incidence And Severity Of Diarrhea With Prophylactic Use Of Neonorm Calf Published In Journal Of Dairy Science

Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

These 5 Stocks Under $10 Could Explode Up Soon

These 5 Stocks Under $10 Could Explode Up Soon

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

Jaguar Animal Health Enters Binding Agreement Of Terms To Merge With Napo Pharmaceuticals

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Begins Entry Into Organic Market With Neonorm Calf

Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health, Elanco Enter Global Collaboration For Development, Co-Promotion Of Canalevia

Jaguar Animal Health, Inc. (NASDAQ: JAGX) and Elanco US Inc.

Jaguar Animal Health To Participate In Biotech Showcase 2017 Week Of January 9th In San Francisco

Jaguar Animal Health To Participate In Biotech Showcase 2017 Week Of January 9th In San Francisco

Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Napo Pharmaceuticals Secures $2 Million In Financing

Napo Pharmaceuticals Secures $2 Million In Financing

Napo Pharmaceuticals, Inc. ("Napo"), announced today that it has obtained $2 million in secured convertible debt financing from New York-based Kingdon Capital Management, LLC.

Jaguar Animal Health Appoints Dr. Ari Azhir To Board Of Directors

Jaguar Animal Health Appoints Dr. Ari Azhir To Board Of Directors

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health And Henry Schein, Inc. Sign Exclusive Distribution Agreement For Neonorm Foal

Jaguar Animal Health And Henry Schein, Inc. Sign Exclusive Distribution Agreement For Neonorm Foal

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Exhibits Neonorm Foal At American Association Of Equine Practitioners Annual Convention

Jaguar Animal Health Exhibits Neonorm Foal At American Association Of Equine Practitioners Annual Convention

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Announces Private Placement Of Common Stock And Warrants

Jaguar Animal Health Announces Private Placement Of Common Stock And Warrants

Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Issues Racing Data Summary For Horses Participating In The Company's Recently Completed Dose Determination Study For Its Drug Product Candidate For Equine Gastric Ulcer Syndrome

Jaguar Animal Health Issues Racing Data Summary For Horses Participating In The Company's Recently Completed Dose Determination Study For Its Drug Product Candidate For Equine Gastric Ulcer Syndrome

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Announces Final Topline Results For Proof-of-Concept Study For Secretory Diarrhea In Dogs

Jaguar Animal Health Announces Final Topline Results For Proof-of-Concept Study For Secretory Diarrhea In Dogs

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Napo Pharmaceuticals Launches Mytesi (crofelemer) As The Only FDA-Approved Treatment For Relief Of Noninfectious Diarrhea In HIV+ Patients

Napo Pharmaceuticals Launches Mytesi (crofelemer) As The Only FDA-Approved Treatment For Relief Of Noninfectious Diarrhea In HIV+ Patients

Launch Includes Copay Savings and Patient Assistance Programs to Ensure Affordable Access to Mytesi™, Formerly Marketed as Fulyzaq®

Jaguar Animal Health And Napo Pharmaceuticals Announce Details For Proposed Merger

Jaguar Animal Health And Napo Pharmaceuticals Announce Details For Proposed Merger

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...